rosiglitazone has been researched along with Brain Vascular Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cucullo, L; Sivandzade, F | 1 |
| Arrick, DM; Bamberg, BN; Kim Sawtelle, KR; Mayhan, WG; Saha, PS; Scholl, JL; Watt, MJ; Zheng, H | 1 |
| Chang, YW; Chen, WL; Chou, CC; Kao, TW; Loh, CH; Wang, CC | 1 |
| Araújo, CV; Bozza, PT; Castro-Faria-Neto, HC; Estato, V; Silva, AR; Tibiriçá, E | 1 |
4 other study(ies) available for rosiglitazone and Brain Vascular Disorders
| Article | Year |
|---|---|
Anti-Diabetic Countermeasures Against Tobacco Smoke-Dependent Cerebrovascular Toxicity: Use and Effect of Rosiglitazone.
Topics: Animals; Blood-Brain Barrier; Brain; Cerebrovascular Disorders; Cotinine; Diabetes Mellitus; Humans; Hypoglycemic Agents; Male; Mice, Inbred C57BL; NF-E2-Related Factor 2; Nicotine; PPAR gamma; Rosiglitazone; Signal Transduction; Tobacco Smoking | 2019 |
Rosiglitazone restores nitric oxide synthase-dependent reactivity of cerebral arterioles in rats exposed to prenatal alcohol.
Topics: Animals; Arterioles; Brain; Cerebrovascular Disorders; Ethanol; Female; Male; Nitric Oxide Synthase; Oxidative Stress; PPAR gamma; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Rosiglitazone; Superoxides | 2021 |
Incidence of cardiovascular events in which 2 thiazolidinediones are used as add-on treatments for type 2 diabetes mellitus in a Taiwanese population.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Antihypertensive Agents; Cardiovascular Diseases; Cerebrovascular Disorders; Chi-Square Distribution; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Incidence; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pioglitazone; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Rosiglitazone; Taiwan; Thiazolidinediones; Time Factors; Treatment Outcome | 2011 |
PPAR gamma activation protects the brain against microvascular dysfunction in sepsis.
Topics: Animals; Anti-Inflammatory Agents; Brain; Cecum; Cerebrovascular Circulation; Cerebrovascular Disorders; Cytoprotection; Disease Models, Animal; Leukocyte Rolling; Ligation; Male; Mice; Microcirculation; Microvessels; Neutrophil Infiltration; PPAR gamma; Punctures; Rosiglitazone; Sepsis; Thiazolidinediones | 2012 |